Year: 2021
Type: article
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States and in other industrialized nations.Its increase in prevalence and severity correlates with the rise in obesity and the metabolic syndrome, and NAFLD now represents a leading indication for liver transplantation in the United States. 1 The rising clinical and economic burden of NAFLD has highlighted the need for a streamlined approach to prevention, diagnosis, and treatment of the disease.In this review, we will summarize updated guideline and guidance recommendations for the management of adult NAFLD; highlight key difference between US, Asian, and European recommendations; and provide key updates. KeY UPDaTes TO Us GasTrOenTerOlOGY anD HePaTOlOGY sOCieTY reCOMMenDaTiOns FOr aDUlT naFlDIn 2012, the American Association for the Study of Liver Diseases (AASLD), the American College of Gastroenterology, and the American Gastroenterological Association published a joint practice guideline on NAFLD. 2 The diagnosis of NAFLD currently requires: (1) evidence of hepatic steatosis (HS) by imaging or histology, (2) no significant alcohol consumption, (3) no competing causes of HS, and (4) no coexisting causes of chronic liver disease.Research efforts have led to significant progress in our understanding of the disease.An updated practice guidance, based on expert consensus rather than by systematic review of the literature,
Source: Clinical Liver Disease
DOI: 10.1002/cld.1045
Authors: Yumi Ando, Janice H. Jou
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3127981559